Live tape
Top 8, mentions 7d6,091META1,645 mentions▲ +0.06GOOGL1,180 mentions▲ +0.04NVDA788 mentions▲ +0.09TSLA530 mentions▲ +0.05MSFT528 mentions▲ +0.06AMZN494 mentions▲ +0.04SPY481 mentions▲ +0.03RBA445 mentions▲ +0.05

Equity · Healthcare

ASND

NASDAQ

Ascendis Pharma A/S

$228 −0.87% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 29, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$280 $220 2 Jul 29 Sep

The line runs $275 on 2 July through $228 on 29 September, on a scale from $220 to $280. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of ASND over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $275 on 2 July 2026 through $228 on 29 September 2026.

52-week range $189.56 – $277
Avg volume 44.2K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Sep 29, 2026

ASND insider trades

SEC Form 4 · last 90 days · newest reported trade 8 Sep 2026
Open-market buys 1
Open-market sells 2
Net sold $380K
Non-trade filings 1
Date Insider Type Shares Value
08 Sep 2026 Bodenhoff Mads SVP & PAO Sell 3,000 $811K
02 Sep 2026 HOLTUG LARS Director Sell 236 $62K
14 Aug 2026 BIENAIME JEAN JACQUES Director Buy 2,000 $493K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Sep 2026 Bodenhoff Mads SVP & PAO Option exercise 3,000 $330K

ASND institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a ASND position for the quarter ended 30 Jun 2026 — a combined $248.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments New position 305,803 $81.6M
Millennium Management New position 266,708 $71.1M
Citadel Advisors New position 137,889 $36.8M
Renaissance Technologies New position 119,699 $31.9M
Balyasny Asset Management New position 31,023 $8.3M
D. E. Shaw & Co. New position 30,883 $8.2M
Marshall Wace New position 22,503 $6.0M
Tudor Investment Corp New position 16,625 $4.4M
AQR Capital Management Exited
D. E. Shaw & Co. Exited

Source: SEC EDGAR 13F filings

ASND fails-to-deliver

SEC CNS data

On 02 Sep 2026, 974 shares of ASND failed to deliver (about $253K).

Settlement date Shares failed Notional % of shares out
02 Sep 2026 974 $253K 0.002%
24 Aug 2026 301 $76K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in ASND

STOCK Act disclosures

The most recent congressional trade disclosed in ASND is a purchase by Gary J. Palmer (house, AL), dated 12 Jul 2018.

Date Member Type Amount
12 Jul 2018 filed 29 Sep 2018 Gary J. Palmer house · Republican–AL Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures